@GenomicPath
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Loves all things Genomics
Joined July 2011
- Tweets652
- Following77
- Followers265
- Likes256
Getting ready to travel to #estonia for the #AMPEurope meeting. Excited for the great program and reconnecting with @AMPath friends. See you there!
amp-europe-congress.com
@GreenMtnEnergy you have my hourly #energy consumption #data but #customerservice cannot make it available to me. Why?
#AMPEurope started today with a bang!!! Great talks on implementation of #newbornsequencing, identification of disease causing rearrangements in #noncodingrna, #artificialintelligence #genetics and #pathology
@AMPath #molecularpathology #moleculardiagnostics
Come visit #delphidiagnostics at #ASCO24 and learn all about our Endocrine Activity Index (EAI) test.
Also, checkout posters 157 and 130 for new data. #oncology #asco ##breastcancer #prognosis
Just a few more days for #AMPEurope2024!! Looking forward to an amazing conference. @AMPath #moleculardiagnostics #genomics #molecularpathology #biomarkers #precisionmedicine
Federico Monzon retweeted
Thank you @ClinGenResource , @HeidiRehm, @UDNIss , #wilhelmFoundation @BaylorGenetics @H3Africa @Unikinrdc and all of you, not mentioned in this tweet, for your commitment to supporting the @ARDI_Africa
Very happy to announce that we have been awarded a #R01 grant by the #NIH @genome_gov to help advance genomic medicine through Rare Diseases research in Africa:
11 clinical sites,
1 mobile App, 1 EHR, 1 registry, 900 WGS analyzed in #DRC, +++ diversity in databases
++ partners
Today is the 10th anniversary of the #SCOTUS decision to invalidate #genepatents in their ruling for #ampvsmyriad and opened the door to unprecedented developments in #genetictesting and #moleculardiagnostics
#AMPlify @AMPath #celebrate
Learn more at: amp.org/advocacy/reflecting-…
Good morning @Uber
Tried to book a trip from @MidwayAirport but your app did not let me even though I was in #rideshare pickup area. Had to use other service.
This is a failure of the #UShealthcaresystem in #coloncancer #screening. Most worrysome is that there was an shift towards #advanceddisease #diagnoses
Shift to earlier ages likely represents #diet and #lifestyle choices in the US.
washingtonpost.com/wellness/…
nobelprize.org/prizes/medici…
Paleogenomics wins the Nobel Prize!!!
#genomics #genomicmedicine #genomicsciences
Federico Monzon retweeted
"The U.S. is once again facing a testing shortage, which will only be further exacerbated by FDA’s plans to pull what the agency deems to be “non-priority #COVID19 tests” off the market as early as February... Now is not the time to reduce laboratory capacity."
AMP statement on actions needed to address the spread of the #Omicron #COVID19 Variant in the U.S.
#molpath #IDTwitter #pathologists
Federico Monzon retweeted
Welcome to Day 2 of the #AMPath21 Digital Experience! Today, we look forward to sessions with @VanAllenLab & @AshAlizadeh, as well as corporate workshops with @PGDx_ @CanexiaHealth, @AstraZeneca & @10xGenomics. #molpath
Federico Monzon retweeted
#AMPath21 Digital Experience today @PGDx @CanexiaHealth #MachineLearning @AstraZeneca @10xGenomics #lymphoma @AMPath business meeting
If you are considering a #COVID19 test, this blog explains the types of tests available and when they might be useful. Great job by the @AMPath Covid Response Committee. #RTPCR #pcrtest #covidtests #antigentests
amp.org/about/news-room/amp-…
Thank you @Tesla for the new #supercharger in #centervilletx!!! Makes the trip from #houston to #dallas much better.
Federico Monzon retweeted
Did I do this correctly?
Types of #Pathology Paper.
PS: Many Thanks to @g_levrier for the @xkcd paper generator.
Federico Monzon retweeted
For something that is such a vital and integral part of #PatientCare why are #MolPath #MolDx efforts not adequately reimbursed under current payer systems? amp.org/AMP/assets/File/advo…
